| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 28.95B | 34.60B | 36.98B | 34.87B | 29.61B | 26.93B |
| Gross Profit | 14.24B | 17.66B | 19.50B | 17.90B | 13.11B | 12.98B |
| EBITDA | 2.60B | 5.21B | 6.69B | 5.72B | 1.62B | 2.59B |
| Net Income | 886.00M | 2.57B | 3.64B | 5.30B | -1.78B | 122.00M |
Balance Sheet | ||||||
| Total Assets | 49.72B | 54.93B | 52.55B | 51.16B | 45.40B | 51.82B |
| Cash, Cash Equivalents and Short-Term Investments | 16.88B | 21.65B | 20.13B | 20.40B | 19.48B | 18.79B |
| Total Debt | 914.00M | 3.00M | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 5.92B | 8.15B | 9.61B | 11.37B | 8.78B | 10.99B |
| Stockholders Equity | 43.80B | 46.78B | 42.94B | 39.79B | 36.63B | 40.83B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.36B | 1.54B | 4.40B | 982.00M | -2.05B |
| Operating Cash Flow | 0.00 | 4.61B | 3.73B | 5.51B | 3.07B | -52.00M |
| Investing Cash Flow | 0.00 | -2.02B | -2.47B | -911.00M | -1.36B | -1.36B |
| Financing Cash Flow | 0.00 | -1.17B | -1.13B | -3.47B | -1.12B | -1.12B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥21.07B | 5.47 | ― | 1.27% | 12.08% | 17.87% | |
76 Outperform | ¥21.10B | 63.30 | ― | 5.22% | -58.15% | -183.95% | |
66 Neutral | ¥22.03B | 7.10 | ― | 0.76% | 20.69% | 17.46% | |
63 Neutral | ¥406.80B | 21.16 | 10.65% | 1.64% | 14.75% | 22.10% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | ¥14.62B | 2.42 | ― | 0.55% | 35.22% | 413.40% | |
55 Neutral | ¥6.29B | 12.92 | ― | 2.41% | <0.01% | 23.81% |